Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Effects of L-000124467 on Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis as Measured by MRI.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 May 2011
Price :
$35
*
At a glance
- Drugs L 000124467 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 10 May 2011 New trial record